Method and apparatus for processing blood and blood components

Information

  • Patent Grant
  • 6740239
  • Patent Number
    6,740,239
  • Date Filed
    Friday, November 30, 2001
    23 years ago
  • Date Issued
    Tuesday, May 25, 2004
    20 years ago
Abstract
The claimed invention relates to a method and a device for processing blood concentrate products before they are exposed to a continued process for extracting those remaining medicinally interesting sub-components. The appropriate pre-processing, in relation to the invention, primarily entails a mechanically powered resolution of the viscous flowing concentrate products in a diluting solution for the adaptation of the total products for a renewed centrifuging. The device includes a centrifuge machine containing one or more suspended product bags that can be oscillated forwards and backwards in an incomplete pendulum swing by operation of a motor mounted in a lid of the machine. The product bag(s) are connected to a ring bag for subsequent processing and to a bag containing diluting solution by a multi-way connector.
Description




This application claims the benefit of International PCT Application No. PCT/SE00/01077 filed 26 May 2000, which claims priority from Swedish Patent Application No. 9903841-6 filed 26 Oct. 1999.




BACKGROUND OF THE INVENTION




The claimed invention relates to a method and an apparatus for pre-processing blood concentrate products before they are exposed to continued processing for extracting those remaining subcomponents that are of interest. The pre-processing of blood concentrate products, primarily pertaining to the invention, entails a resolution of these in a diluting solution and a flushing of the containers or bags in which the blood concentrate products are delivered. This makes possible the following processing operation in the form of centrifuging and the dividing up of blood concentrate products into blood-platelet plasma and waste products.




The invention is primarily intended for pre-processing of such blood concentrate products that are designated “Buffy Coat” at blood-donor centres and which are obtained from red blood cells and plasma from whole blood and which at present are utilised for extracting valuable medicinal blood-platelet plasma. At this stage the Buffy Coat is a thick viscous liquid that must be resolved in a suitable diluting solution before it can be exposed to renewed centrifuging. An example of such a standardised diluting solution, which is widely used, is generally designated T-Sol. In normal cases the Buffy coat is accessible in the form of concentrate from the previous extraction of red blood cells and plasma from whole blood. Each concentrate batch of Buff, Coat is, as a rule, too small to be worth an individual centrifuging after resolution in the current diluting solution. As every Buffy Coat concentrate is initially accessible in its own blood processing bag, a decided amount of diluting solution was previously added manually to each one of a certain amount of blood processing bags and shaken manually until an acceptable mixing had taken place, followed by emptying them together into a larger bag which was then centrifuged.




Apart from the manual handling and the time required for this there is also the added risk to the person who must shake the blood bags and in the long term can receive injury to the neck and shoulders.




SUMMARY OF THE INVENTION




To be able to also automate this stage in blood processing it is suggested, in accordance with the claimed invention, the use of a specially intended set of bags preferably containing a ring-shaped bag for the following centrifuging operation as well as the use of a characteristic automatic mixing device, special to the invention, in which the Buffy coat is added and resolved in a diluting solution. In the design of this part of the invention, preferred, by us the mixing function or the mixing device has been built into or made connectable to the outer lid of the centrifuge that is utilised in the processing stage that follows after. Nevertheless, the device can also be made to stand completely by itself without changing the original concept. In the device, in accordance with the invention, a smaller electrically driven motor is thus included which, when the device is combined with the centrifuge, is secured to the lid of the centrifuge. This motor has the distinct feature of never doing a complete revolution in any direction but is quickly stopped before a revolution is completed then followed by an incomplete revolution in the opposite direction. A movement of approximately one of quarter revolution (such as +92°), at the most lasting several minutes, has shown that it gives the desired mixing function, which, as shown as follows, has, as its task the replacement of the prior manual resolution of the Buffy Coat and the flushing out of the Buffy Coat bags with the required amount of diluting solution, which, today was generally preceded by Pooling, in other words, the merging of several flushed out quantities of concentrate products to form a mass that is suitable for centrifuging. The device's special movement pattern can be attained with a gear box, a crank function or via the control of its motor. In theory, a hydraulic motor could also be used for this purpose although a longer shaking rate and a longer mixing time should be taken into account. Connected to the aforementioned motor there is a cassette or holder in which the number of concentrate bags with Buffy Coat intended to be included in a process can be connected. Before the concentrate bags are connected to the cassette they have been individually connected by sterile welding to individual connecting tubes then to the bag set intended for processing, which, in turn, leads to a connecting tube with which all bags containing Buffy Coat can be joined to a bag with the required amount of diluting solution, as well as via a second connecting tube to the ring bag intended for finishing centrifuging and finally to a connecting tube between the ring bag and a storage bag for the desired final product. Together these components make up a functionally sealed system which is easy to handle and completely protected against external bacteria, etc.




When extracting blood platelet plasma from the Buff coat the number of bags with the original material that are intended for centrifuging are connected to individual connecting tubes in the aforementioned bag set. These connecting tubes are then connected, each in turn, to a multi-way connector to which the connecting tube form the diluting solution bag is also connected. A clamp valve is applied to the latter connecting tube while the bags with Buffy Coat are secured to the aforementioned cassette and the bag with the diluting solution is suspended in the intended holder sufficiently high up to allow the desired amount of diluting solution to be transferred to each respective Buffy Coat bag. The addition of the diluting solution to the Buffy Coat bags is then controlled by the clamp valve, which, in turn, is controlled by a control program that can be included in the control program of the control system of the centrifuge, which also selects the time to start the motor and the time it must be operated. Appropriately, the diluting solution is added in several portions with a motor driven action between each addition. Dissolving the Buffy Coat in the diluting solution is thus carried out without any manual shaking operation. Due to the special timed movement, back and forth, of the motor the problem of damaging the different tubes is avoid. It is only the ring bag and the tube between it and the final product's storage bag that are affected by the mixing operation. After the dissolution of the Buffy Coat in the different exit bags is finalised the content of all bags are added to the bag set included in the ring bag via a separate connecting tube, which also is connected to the previously named multi-way connector and which on its way to the ring bag is placed in a clamp valve by which this connection is controlled. After all substance has been transferred to the ring bag the connection is interrupted between the ring bag and the exit bags and the diluting solution bag, the appropriate connecting tube is removed by welding from the centrifuge rotor support which it passes, after which the empty bags and their connecting tubes can be rejected. Following this the diluting solution/Buffy Coat mix is centrifuged while the bag intended for storing the end product is located in the centre chamber of the centrifuge rotor. After centrifuging the lighter blood platelet product is transferred to the final storage bag. The designed device is utilised in a known way to expose the ring bag to an outer pressure thus emptying it to a greater or lesser degree. This device consists of a membrane arranged under the ring bag under which hydraulic fluid can be added and therefore expose the ring bag to an external pressure. When emptying the ring bag must be interrupted it is determined by one or more photocells in the outer lid of the centrifuge, which utilise the difference in colour between the light desired blood-platelet's end product and those dark heavy concentrate products that are gathered along the outer periphery. When emptying the ring bag it is suitable to do it via the already described cell trap, which can, for example, be one of the types, described in WO 97/30715. After the desired amount of blood-plateiet plasma has been removed from the ring bag the connecting tube between the ring bag and final storage bag is welded in a known way and thereby blocking the ends of both tubes. All that remains after that is to point out that the holder for the diluting solution bag and cassette for the Buffy Coat bags can be made removable in order not to interfere with the other functions of the centrifuge.











BRIEF DESCRIPTION OF THE DRAWINGS




The invention in its various functions has now been defined in the subsequent patent claims and they shall now only be somewhat more described in relation to the attached figures.




Of these





FIG. 1

a bag set intended for blood-platelet production from Buffy Coat.





FIG. 2

angle projection of the equipped centrifuge in accordance with the invention for autopooling.











DETAILED DESCRIPTION OF THE INVENTION




The bag shown in

FIG. 1

for blood-platelet production from Buffy Coat comprises ring bag


22


, a bag for diluting solution


23


, four connecting tubes


25


-


28


(the number of connecting tubes can vary but should as a rule be between


4


and


6


), each one is intended for welding to one bag of Buffy Coat, a multi-way connector


29


which, on the one hand, is connected via tube


30


to the diluting solution bag


23


and, on the other hand, to another tube


31


to ring bag


22


. From the latter there is one more tube


32


that finally goes to final storage bag


33


. In tube


30


connecting to diluting solution


23


there is a breaker switch


45


, which, when required to add the diluting solution to tubes


25


-


28


, which are connected to the bags with Buffy Coat, can be opened by sharply bending the tube. Before the breaker switch is opened the connecting tube


30


must be engaged in guide groove


12


in one of the supports


9


-


11


with which the clamp valve function is intended to control the added diluting solution.




As the bag set shown in

FIG. 1

is the same as illustrated in

FIG. 2

we have retained the same notations although the parts are drawn to a smaller scale and consequently also with fewer parts. Otherwise, in

FIG. 2

centrifuge


34


is shown standing with its outer lid


35


completely open and locked in position. The inner lid of the centrifuge has not been taken into account in the figure as it made the figure unclear when drawn in position. Also the centrifuge rotor and ring bag


22


has been drawn, to a certain extent, in a simplified way. The control panel of the centrifuge is numbered


36


in the figure. Furthermore, the figure shows a position with four blood bags of Buffy Coat


37


-


40


suspended in a cassette


41


, which is mounted on the outer lid of the centrifuge. The respective outlets of blood bags


37


-


40


have, by sterile welding, been connected to tube connectors


25


-


28


and the fluid content of the bags has been transferred to ring bag


22


via these tubes and connecting tube


31


. After that, bags


37


-


40


have received cleaning and diluting fluid from the diluting fluid bag


23


suspended in holder


44


. Diluting fluid bag


23


is suspended sufficiently high above bags


37


-


40


to enable the diluting solution, in sufficient amounts, to be added to the bags as soon as breaker switch


45


in tube


30


and clamp valve in support


11


, which tube


30


passes, is opened. Communication between bags


37


-


40


and ring bag


22


is via tube


31


which, in turn, passes clamp valve in support


10


by which communication is controlled. As the addition of diluting solution in sufficient amounts to the bags


37


-


40


starts with the cassette connected motor (not seen on the figure) that operates cassette


41


forwards and backwards in a pendulum movement, in accordance with curve


42


, until all the concentrate substance in the Buffy Coat bags has dissolved, after which the built-in clamp valve on support


10


opens up, which outlet tube


31


from multi-way connector


29


passes through and all substance is added to ring bag


22


after which tube


31


, in support


10


is sterile welded and blocked whereby the empty bags


37


-


40


and bag


23


with the concentrate from the diluting solution can be rejected together with the tube system. Flushing out of the blood bags can, if, necessary be carried out as two or several consecutive flushing stages. After the prepared flushing of the blood bags cassette


41


and holder


44


are removed from the centrifuge lid the centrifuge is closed and centrifuging is carried out. Final storage bag


33


is located in centre chamber


45


of the centrifuge. After centrifuging all blood-platelet plasma is transferred to final storage bag


33


via location


5


, under the ring bag, being supplied by hydraulic fluid which exposes the bag to an outer pressure which clamps it together. Emptying the ring bag is interrupted by photocell


52


when it registers that the interface between the desired lighter substance and the darker non-desired concentrate product starts to reach the outlet via tube


32


. Following this, tube


32


is sterile welded and sealed in one of the supports


9


-


11


, after which the ring bag with the non-desired concentrates of red blood cells, etc. can be rejected.



Claims
  • 1. A method for processing a blood concentrate product for separating a medicinally valuable blood component comprising: connecting at least one product bag containing a blood concentrate product to be proceased with a tube system having a plurality of tubes connected to a multi-way connector and connecting also a solution bag containing a diluting solution via a solution tube to the tube system in communication with the multi-way connector, suspending the at least one product bag containing the blood concentrate product to be processed in a cassette, processing the blood concentrate product in the at least one product bag by oscillating the cassette forwards and backwards in an incomplete pendulum swing, adding the diluting solution from the solution bag through the tube system in an adapted portion to each of the at least one product bags, keeping the cassette in motion until all blood concentrate products are dissolved in the added diluting solution, and transferring the contents of all of the at least one product bags in the cassette to a ring bag for a subsequent centrifugation processing step.
  • 2. A method in accordance with claim 1 whereby the amount of diluting solution added to the at least one product bag is controlled by a clamp valve through which the solution tube is passed and which clamp valve optionally utilized when processing is finalized to weld the solution tube.
  • 3. A method in accordance with claim 1 whereby the pendulum movement of the cassette is held within approximately a quarter revolution in either the forward or backward direction.
  • 4. A method in accordance with claim 1 whereby the step of transferring to the ring bag the contents of all of the at least one product bags containing a blood concentrate product occurs after the steps of adding and processing.
  • 5. A method in accordance with claim 1 in which the step of adding the diluting solution and the step of transferring the concentrate products takes place in several steps with mixing as the middle step.
  • 6. A method in accordance with claim 1, in which the steps of oscillating the cassette and adding diluting solution occur at least partially at the same time.
  • 7. A method in accordance with claim 1, whereby the connecting step comprises connecting a plurality of blood product bags each containing a blood concentrate product to be processed; and whereby said step of adding a diluting solution includes adding diluting solution to each of the plurality of product bags.
  • 8. A method in accordance with claim 7, whereby said step of adding a diluting solution includes flowing the diluting solution to each of the plurality of product bags through the multi-way connector.
  • 9. A method in accordance with claim 9, whereby the step of transferring includes transferring the contents of each of the plurality of product bags to the ring bag.
  • 10. A method in accordance with claim 9 whereby said step of transferring includes flowing the contents of each of the plurality of product bags to the ring bag through the multi-way connector.
  • 11. A method in accordance with claim 1 which further comprises a step for removing a processed blood component from the ring bag after the subsequent centrifugation processing step.
  • 12. A bag set for processing blood concentrate products comprising a ring bag, a processed component bag connected to the ring bag, a multi-way connector connected to the ring bag, one or more connecting tubes that are adapted to be individually connected to one or more discrete sources of blood concentrate products, said one or more connecting tubes also being connected to the multi-way connector and a diluting solution tube connected to the multi-way connector, the diluting solution tube being adapted to be connected to a discrete source of diluting solution, said multiway connector selectively connecting the one or more connecting tubes and the diluting solution tube or the one or more connecting tubes and the ring bag whereby the source of diluting solution can be connected with each discrete source of blood products placing diluting solution in fluid communication with said blood products, and whereby each discrete source of blood products can be connected with the ring bag, emptying said blood products and diluting solution from said discrete sources of blood concentrate products into said ring bag, while the processed component bag is separately connected to the ring bag.
  • 13. A device for processing a blood concentrate product comprising a centrifuge machine to which is connected a cassette in which a plurality of product bags containing blood concentrate products to be processed are suspended and having means for putting the cassette in motion in a forward and backward pendulum movement in an incomplete revolution about the axis and said means comprising an outer lid which has a motor disposed therein which operates in an incomplete revolution in one direction immediately followed by a corresponding incomplete return revolution in the other direction, said motor being operably connected to the cassette such that when the outer lid of the centrifuge is in an open position, a plurality of product bags can be suspended in the cassette, so that when the motor is activated the product bags are exposed to a mechanical mixing of the blood concentrate products disposed therein.
  • 14. A device in accordance with claim 13 in which the centrifuge machine further has attached thereto an instrument for holding a bag containing a diluting solution.
  • 15. A device in accordance with claim 13 whereby the pendulum movement of the cassette is maintained within the interval of approximately a quarter revolution forward and backward.
  • 16. A device for processing a blood concentrate product in accordance with claim 13, which further comprises a clamp valve through which a diluting solution tube may be passed whereby the diluting solution tube is connected between a diluting solution bag and the plurality of blood product bags, and whereby an amount of diluting solution is added to the plurality of product bags, the amount of diluting solution being controlled by the clamp valve.
  • 17. A device for processing a blood concentrate product in accordance with claim 16, whereby the clamp valve is adapted to also be utilized when processing is finalized to weld the diluting solution tube.
  • 18. A device for processing a blood concentrate product in accordance with claim 16, which further comprises a support which has a controllable clamp and a welding station which can be actuated to block or weld a diluting solution tube adapted to be disposed therein.
  • 19. A device for processing a blood concentrate product in accordance with claim 16, which further comprises a second clamp valve to control the flow of processed blood concentrate product from the plurality of product bags to a ring bag via a tube connecting the product bags to the ring bag.
Priority Claims (1)
Number Date Country Kind
9903841 Oct 1999 SE
US Referenced Citations (73)
Number Name Date Kind
3096283 Hein Jul 1963 A
3145713 Latham, Jr. Aug 1964 A
3244363 Hein Apr 1966 A
3326458 Meryman et al. Jun 1967 A
3329136 Cadlou Jul 1967 A
3456875 Hein Jul 1969 A
3489145 Judson et al. Jan 1970 A
3519201 Eisel et al. Jul 1970 A
3600900 Buddecke Aug 1971 A
3679128 Unger et al. Jul 1972 A
3708110 Unger et al. Jan 1973 A
3724747 Unger et al. Apr 1973 A
3737096 Jones et al. Jun 1973 A
3858796 Unger et al. Jan 1975 A
3864089 Tiffany et al. Feb 1975 A
3885735 Westbert May 1975 A
3987961 Sinn et al. Oct 1976 A
4010894 Kellogg et al. Mar 1977 A
4016828 Maher, Jr. et al. Apr 1977 A
4018911 Lionetti et al. Apr 1977 A
4111355 Ishimaru Sep 1978 A
4131369 Gordon et al. Dec 1978 A
4132439 Millar Jan 1979 A
4142670 Ishimaru et al. Mar 1979 A
4230263 Westberg Oct 1980 A
4244513 Fayer et al. Jan 1981 A
4268393 Persidsky et al. May 1981 A
4278202 Westberg Jul 1981 A
4303193 Latham, Jr. Dec 1981 A
4304357 Schoendorfer Dec 1981 A
4386730 Mulzet Jun 1983 A
4387848 Kellogg et al. Jun 1983 A
4388184 Brous et al. Jun 1983 A
4389206 Bacehowski et al. Jun 1983 A
4389207 Bacehowski et al. Jun 1983 A
4405079 Schoendorfer Sep 1983 A
4419089 Kolobow et al. Dec 1983 A
4421503 Latham, Jr. et al. Dec 1983 A
4439177 Conway Mar 1984 A
4447221 Mulzet May 1984 A
4459169 Bacehowski et al. Jul 1984 A
4482342 Lueptow et al. Nov 1984 A
4530691 Brown Jul 1985 A
4617009 Öhlin et al. Oct 1986 A
4720284 McCarty Jan 1988 A
4767397 Hohenberg et al. Aug 1988 A
4846780 Galloway et al. Jul 1989 A
4850952 Figdor et al. Jul 1989 A
4925442 Bodelson May 1990 A
4934995 Cullis Jun 1990 A
4936820 Dennehey et al. Jun 1990 A
4940543 Brown et al. Jul 1990 A
4990132 Unger et al. Feb 1991 A
5006103 Bacehowski et al. Apr 1991 A
5032288 Columbus et al. Jul 1991 A
5114396 Unger et al. May 1992 A
5160310 Yhland Nov 1992 A
5217426 Bacehowski et al. Jun 1993 A
5217427 Cullis Jun 1993 A
5316540 McMannis et al. May 1994 A
5571068 Bacehowski et al. Nov 1996 A
5593378 Dyck Jan 1997 A
5610074 Beritashvili et al. Mar 1997 A
5651766 Kingsley et al. Jul 1997 A
5674173 Hlavinka et al. Oct 1997 A
5704887 Slowik et al. Jan 1998 A
5723050 Unger et al. Mar 1998 A
5733253 Headley et al. Mar 1998 A
5759147 Bacehowski et al. Jun 1998 A
5789259 Wardlaw Aug 1998 A
6261217 Unger et al. Jul 2001 B1
6315706 Unger et al. Nov 2001 B1
6348031 Unger et al. Feb 2002 B1
Foreign Referenced Citations (21)
Number Date Country
38 15 645 Nov 1989 DE
0 304 431 Mar 1989 EP
0 508 474 A2 Oct 1992 EP
0 578 086 Jan 1994 EP
0 935 966 Aug 1999 EP
84 11225 Jan 1986 FR
1373672 Nov 1974 GB
354 581 Mar 1973 SE
354 582 Mar 1973 SE
8502561 Jun 1985 WO
8706844 Nov 1987 WO
8706857 Nov 1987 WO
8902273 Mar 1989 WO
9200145 Jan 1992 WO
9425086 Nov 1994 WO
9501842 Jan 1995 WO
9504591 Feb 1995 WO
9629081 Sep 1996 WO
9835757 Aug 1998 WO
9846362 Oct 1998 WO
0102037 Jan 2001 WO
Non-Patent Literature Citations (2)
Entry
A.H. Runck et al., Continuous-flow Centrifugation Washing of Red Blood Cells, Transfusion, vol. 12, No.4, Jul.-Aug. 1972, pp. 237-244.
T.J. Contreras et al., A Comparison of Methods to Liquid-Stored Red Blood Cells and Red Blood Cells Frozen with High or Low Concentrations of Glycerol, Transfusion, vol. 16, No. 6, Nov. -Dec. 1976, pp. 539-565.